Here are the 10-K annual reports from Treace Medical Concepts, Inc. (TMCI) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow TMCI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TMCI filings page.
Treace Medical Concepts provides an overview of its business focused on surgical solutions for bunions and related midfoot deformities. The company highlights its flagship Lapiplasty 3D Bunion Correction System and complementary platforms such as Adductoplasty, Nanoplasty, Percuplasty, SpeedMTP, SpeedPlate, IntelliGuide, and a hammertoe system.
The filing describes a U.S.-focused commercial model with a 297-person field sales fleet and extensive surgeon training and direct-to-patient marketing, including National Bunion Day. It outlines large addressable markets for bunion surgery, summarizes favorable interim clinical data from ALIGN3D and Mini3D studies, details an active R&D pipeline including Lapiplasty Lightning, and notes 450 employees, robust patent and trademark portfolios, and a capital‑light manufacturing strategy using third‑party suppliers.